Develops potentially ground-breaking treatments for conditions such as drug addiction and cancer.

Ceptaris Therapeutics (Formerly Yaupon Therapeutics) is developing potentially ground-breaking treatments for conditions such as drug addiction and cancer from compounds found in plants. The most advanced product in Yaupon’s pipeline, Lobeline, is being developed to help drug users hooked on methamphetamines to overcome addition.

Ceptaris Therapeutics was acquired by Actelion Pharmaceuticals in 2013.

Industry: Health
Status: Active

Contact Information

http://www.ceptaris.com/